Author:
Hajarizadeh Behzad,Martinello Marianne,Dore Gregory J.
Publisher
Springer International Publishing
Reference55 articles.
1. Razali K, Thein HH, Bell J, et al. Modelling the hepatitis C virus epidemic in Australia. Drug Alcohol Depend. 2007;91(2–3):228–35.
2. The Kirby Institute. National update on HIV, viral hepatitis and sexually transmissible infections in Australia: 2009–2018. Sydney, Australia: The Kirby Institute, UNSW Sydney; 2020.
3. Hajarizadeh B, Grebely J, McManus H, et al. Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment. J Gastroenterol Hepatol. 2017;32(1):229–36.
4. Sievert W, Razavi H, Estes C, et al. Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia. J Gastroenterol Hepatol. 2014;29:1–9.
5. Alavi M, Janjua NZ, Chong M, et al. Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: an international comparison. J Viral Hepat. 2018;25(5):473–81.